THIMMIAH RAMESH: Open Payments
NPI 1912934340 · WYANDOTTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 18 payments from 9 companies in 2025. Trend: 2023 $150 · 2024 $343 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $77 |
| Exact Sciences Corporation | 4 | $70 |
| Lilly USA, LLC | 4 | $57 |
| Novo Nordisk Inc | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Viatris Specialty LLC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Orexo US, Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, Cologuard Collection Kit, MOUNJARO, Ozempic, VOQUEZNA, PAXLOVID, YUPELRI, BREZTRI.
Industry payments across MI — which companies pay providers there.
